Cited time in webofscience Cited time in scopus

Full metadata record

DC Field Value Language Zhang, Baochun - Choi, Il-Kyu - 2022-07-06T02:32:54Z - 2022-07-06T02:32:54Z - 2022-06-15 - 2022-10 -
dc.identifier.issn 1078-0432 -
dc.identifier.uri -
dc.description.abstract Epstein-Barr virus (EBV), the first identified human tumor virus, infects and takes up residency in almost every human. However, EBV genome-positive tumors arise in only a tiny minority of infected people, presumably when the viruscarrying tumor cells are able to evade immune surveillance. Traditional views regard viral antigens as the principal targets of host immune surveillance against virus-infected cells. However, recent findings indicate that EBV-infected/-transformed B cells elicit both cytotoxic CD8 and CD4 T-cell responses against a wide range of overexpressed cellular antigens known to function as tumor-associated antigens (TAA), in addition to various EBV-encoded antigens. This not only broadens the ways by which the immune system controls EBV infection and prevents it from causing cancers, but also potentially extends immune protection toward EBV-unrelated cancers by targeting shared TAAs. The goal of this review is to incorporate these new findings with literature data and discuss future directions for improved understanding of EBV-induced antitumor immunity, as well as the hopes for rational immune strategies for cancer prevention and therapy. © 2022 American Association for Cancer -
dc.language English -
dc.publisher American Association for Cancer Research -
dc.title Facts and Hopes in the Relationship of EBV with Cancer Immunity and Immunotherapy -
dc.type Article -
dc.identifier.doi 10.1158/1078-0432.CCR-21-3408 -
dc.identifier.scopusid 2-s2.0-85139457133 -
dc.identifier.bibliographicCitation Clinical Cancer Research, v.28, no.20, pp.4363 - 4369 -
dc.description.isOpenAccess FALSE -
dc.subject.keywordPlus EPSTEIN-BARR-VIRUS -
dc.subject.keywordPlus CD4(+) T-CELLS -
dc.subject.keywordPlus TRANSFORMED B-CELLS -
dc.subject.keywordPlus CYTOTOXIC CD4(+) -
dc.subject.keywordPlus ADOPTIVE TRANSFER -
dc.subject.keywordPlus PROTEIN LMP1 -
dc.subject.keywordPlus CLASS-IIRESPONSES -
dc.subject.keywordPlus INFECTION -
dc.citation.endPage 4369 -
dc.citation.number 20 -
dc.citation.startPage 4363 -
dc.citation.title Clinical Cancer Research -
dc.citation.volume 28 -
Files in This Item:

There are no files associated with this item.

Appears in Collections:
Department of New Biology Lab of T-cell Biology and Immunotherapy 1. Journal Articles


  • twitter
  • facebook
  • mendeley

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.